New funding for research investigating how breast cancer resists hormone therapy
Imperial researchers have received funding from Breast Cancer Now for research into new treatments for breast cancer that resists hormone therapy.
Imperial innovation recognised at Patient Experience Network National Awards
The Imperial Clinical Analytics, Research and Evaluation (iCARE) team won the Innovative Use of Technology, Social and Digital Media award.
Menstrual cycle changes during the COVID-19 pandemic linked to lifestyle shifts
A new study finds menstrual cycle irregularities during the pandemic could be linked to shifts in behaviour & lifestyle rather than the virus itself.
Infection of certain neurons with COVID could cause persistent symptoms
New research suggests that COVID-19 can lead to the death of neurons known for regulating sexual reproduction and cause persistent symptoms.
Microbiome-derived metabolite plays key role in kidney and heart health
A new study reveals the kidney's function as a key regulator of a metabolite associated with cardiovascular risk.
GLP1 Receptor Mutations: The key to personalised medicine for diabetes & obesity
New research reveals that mutations in the GLP1 receptor significantly impair insulin secretion, disrupt glucose regulation, and increase adiposity.
MRC funding to develop techniques for precision removal of brain cancer cells
Imperial researchers make up one of four teams receiving £500k to work across disciplines on improving outcomes of hard-to-treat cancers.
MDR researchers celebrated in the latest round of academic promotions
The Department of Metabolism, Digestion & Reproduction is proud to have eleven of its staff recognised in the latest round of Academic Promotions.
Elevating healthcare education: Imperial introduces cutting-edge XR course
Imperial has launched a new online course on Extended Reality (XR) in Healthcare Education and Clinical Practice, now available on Coursera.
Study reveals alarming mortality risk in children with extreme genetic obesity
A new study reveals the dramatic short-term health & education consequences of untreated severe childhood obesity due to leptin signalling deficiency.
